Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)

Federal funding opportunity RFA-CA-25-010 from National Institutes of Health (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• State governments
• Independent school districts
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• For profit organizations other than small businesses
• City or township governments
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Private institutions of higher education
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Special district governments
• County governments
• Small businesses
• Public housing authorities/Indian housing authorities
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

The official record

Similar grants

• Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
  PAR-26-001 · National Institutes of Health · closes May 7, 2027
• Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
  PAR-25-098 · National Institutes of Health · closes January 7, 2027
• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
  PAR-25-081 · National Institutes of Health · closes January 7, 2027
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)
  PAR-25-043 · National Institutes of Health · closes January 7, 2028
• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)
  PAR-25-044 · National Institutes of Health · closes January 7, 2028
• Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
  PAR-25-299 · National Institutes of Health · closes January 7, 2028